Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755)
Clinical trial NCT01544920 · COMPLETED
Trial details
- NCT number
- NCT01544920
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-30
- Primary completion
- 2015-05-19
- Enrollment
- 737
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.